# Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

> **NCT00039741** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 266 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)
- **DRUG:** NNRTIs (EFV, NVP)
- **DRUG:** PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)

## Key facts

- **NCT ID:** NCT00039741
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2009-08
- **Final completion:** 2010-03
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00039741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00039741, "Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00039741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*